4.5 Article

Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy

Journal

INFLAMMATORY BOWEL DISEASES
Volume 22, Issue 12, Pages 2977-2987

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MIB.0000000000000926

Keywords

IFI16; Crohn's disease; autoantibodies

Funding

  1. Regione Piemonte (PAR FSC Asse I Innovazione e transizione produttiva-Bando regionale sulle malattie Autoimmuni e Allergiche)
  2. Letizia Castelli Schubert Foundation

Ask authors/readers for more resources

Background: Inflammatory bowel disease (IBD) is characterized by a chronic inflammation of the gut, partly driven by defects in the expression and function of pattern recognition receptors, including the IFI16 protein. Because this protein is a target for autoantibodies and its aberrant expression was reported in colonic mucosa from active patients with ulcerative colitis, we studied its expression and specific seroresponse in patients with IBD before and after infliximab (IFX) therapy. Methods: Anti-IFI16 antibodies (IgG and IgA subtypes) were measured in the sera of 74 patients with IBD: 48 patients with Crohn's disease (CD) and 26 patients with ulcerative colitis, prospectively harvested before and after IFX therapy. Anti-GP2 antibodies (both IgG and IgA subtypes) were also tested for comparison. The patient antibody statuses were qualitatively and quantitatively associated with disease phenotype and response to IFX therapy. Results: Significantly higher titers of anti-IFI16 IgG were found in both CD and ulcerative colitis patients compared with healthy controls. Anti-IFI16 IgA titers were also present in patients with CD. Anti-GP2 IgG subtype titers were significantly increased in patients with CD, as were IgA subtype titers. Significant changes in anti-IFI16 IgG subtype titers were observed after IFX in patients with CD who correlated with clinical remission or response. Conclusions: Our results highlight the importance of IFI16 in IBD pathogenesis showing that its de novo overexpression in the gut epithelial cells leads to a breakdown in immune tolerance and the subsequent development of specific autoantibodies. Anti-IFI16 IgG antibodies hold the potential to serve as a biomarker of response to IFX therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dermatology

Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed Human Papillomavirus Type 8-Transgenic Mice

Cinzia Borgogna, Licia Martuscelli, Carlotta Olivero, Irene Lo Cigno, Marco De Andrea, Valeria Caneparo, Renzo Boldorini, Girish Patel, Marisa Gariglio

Summary: The combination of HPV infection, immune defects, and UVB exposure promotes skin cancer development.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Endocrinology & Metabolism

Transition in endocrinology: predictors of drop-out of a heterogeneous population on a long-term follow-up

F. Prodam, M. Caputo, M. Romanisio, S. Brasili, M. Zavattaro, M. T. Sama, A. Ferrero, S. Costelli, F. R. Lenzi, A. Petri, E. Basso, S. Bellone, G. Aimaretti

Summary: This study evaluated the clinical and epidemiological characteristics of outpatients transitioning from Pediatric Endocrine Department to Adult Endocrine Department in a tertiary center, as well as the features of the transition process and predictors of drop-out. The findings showed that the patients were heterogeneous, with different ages, follow-up durations, and types of endocrine diseases. The number of visits was associated with the number and type of endocrine diseases, and adherence to follow-up was predicted by thyroid disorders and multiple comorbidities. A study exploring a specific transition plan for chronic endocrine diseases.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Pediatrics

Evolution of Subclinical Hypothyroidism Diagnosed in the First 3 Months of Life in Newborns Living in North Italy: A Retrospective Cohort Study

Valentina Mancioppi, Valentina Antoniotti, Arianna Solito, Elisabetta Mingoia, Alice Monzani, Giulia Genoni, Ivana Rabbone, Flavia Prodam, Simonetta Bellone

Summary: This study investigated subclinical hypothyroidism in newborns and observed the changes in thyroid hormone levels over time until four years of age. The results showed that more than half of the newborns did not require treatment and had either normal or slightly increased thyroid function. The study also suggested the importance of long-term follow-up to monitor thyroid hormone levels.

CHILDREN-BASEL (2023)

Article Dermatology

SARS-CoV-2 detection by digital polymerase chain reaction and immunohistochemistry in skin biopsies from 52 patients with different COVID-19-associated cutaneous phenotypes

Angelo Valerio V. Marzano, Chiara Moltrasio, Giovanni Genovese, Marco De Andrea, Valeria Caneparo, Pamela Vezzoli, Denise Morotti, Paolo Sena, Marina Venturini, Simonetta Battocchio, Valentina Caputo, Nathalie Rizzo, Carlo Alberto Maronese, Luigia Venegoni, Francesca Laura Boggio, Franco Rongioletti, Piergiacomo Calzavara-Pinton, Emilio Berti

Summary: This study aimed to investigate the relationship between COVID-19 and skin manifestations, and found that SARS-CoV-2 was detected in only 38% of patients' skin samples. The research suggests that the occurrence of skin lesions mainly depends on the activation of the immune system, rather than a specific cutaneous phenotype.

DERMATOLOGY (2023)

Article Gastroenterology & Hepatology

Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis

Marietta Iacucci, Tommaso Lorenzo Parigi, Rocio Del Amor, Pablo Meseguer, Giulio Mandelli, Anna Bozzola, Alina Bazarova, Pradeep Bhandari, Raf Bisschops, Silvio Danese, Gert De Hertogh, Jose G. Ferraz, Martin Goetz, Enrico Grisan, Xianyong Gui, Bu Hayee, Ralf Kiesslich, Mark Lazarey, Remo Panaccione, Adolfo Parra-Blanco, Luca Pastorelli, Timo Rath, Elin S. Royset, Gian Eugenio Tontini, Michael Vieth, Davide Zardo, Subrata Ghosh, Valery Naranjo, Vincenzo Villanacci

Summary: An artificial intelligence computer-aided diagnosis system was developed and validated to evaluate UC biopsies and predict prognosis. The system showed high accuracy and sensitivity in assessing biopsy results and predicting outcomes.

GASTROENTEROLOGY (2023)

Article Endocrinology & Metabolism

AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report

Cristina Partenope, Quincy Pedranzini, Antonella Petri, Ivana Rabbone, Flavia Prodam, Simonetta Bellone

Summary: The report presents a case of a 16-year-old boy who developed polyuria, polydipsia, and weight loss after receiving the COVID-19 vaccine. Diagnosis revealed neuroinfundibulohypophysitis, a rare disorder characterized by inflammation of the pituitary gland and stalk. Further studies are needed to explore the possible causal link between the COVID-19 vaccine and AVP deficiency.

FRONTIERS IN ENDOCRINOLOGY (2023)

Review Cell Biology

Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?

Laura Francesca Pisani, Isabella Teani, Maurizio Vecchi, Luca Pastorelli

Summary: Accumulating evidence suggests that Interleukin-33 (IL-33) plays crucial roles in various aspects, including tissue homeostasis and repair, type 2 immunity, inflammation, and viral infection. It has been found to contribute to tumorigenesis and regulate angiogenesis and cancer progression in different types of human cancers. This review focuses on the basic biology and release mechanisms of IL-33 protein, as well as its involvement in the onset and progression of gastrointestinal cancer.

CELLS (2023)

Article Gastroenterology & Hepatology

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

Cristina Bezzio, Marta Vernero, Stefania Costa, Alessandro Armuzzi, Gionata Fiorino, Sandro Ardizzone, Jenny Roselli, Sonia Carparelli, Ambrogio Orlando, Flavio Andrea Caprioli, Fabiana Castiglione, Chiara Vigano, Davide Ribaldone, Fabiana Zingone, Rita Monterubbianesi, Nicola Imperatore, Stefano Festa, Marco Daperno, Ludovica Scucchi, Antonio Ferronato, Luca Pastorelli, Eleonora Alimenti, Paola Balestrieri, Chiara Ricci, Maria Cappello, Carla Felice, Francesca Coppini, Patrizia Alvisi, Imma Di Luna, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Simone Saibeni

Summary: This study compared the characteristics and outcomes of inflammatory bowel disease (IBD) patients with SARS-CoV-2 infection between the two pandemic waves in Italy. The patients in the first wave were older, more likely to have ulcerative colitis and comorbidities, and resided more frequently in Northern Italy. The rates of negative outcomes, such as pneumonia, hospital admission, ventilatory support, and death, were significantly higher in the first wave compared to the second wave.

BMC GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group)

Chiara Vigano, Andrea Palermo, Giacomo Mulinacci, Lorena Pirola, Alessandra Losco, Gianmichele Meucci, Simone Saibeni, Luca Pastorelli, Arnaldo Amato, Mario Gatti, Claudio Cortelezzi, Antonio Di Sabatino, Daniela Morganti, Francesca Boni, Gianalberto Grasso, Giovanni Casella, Valentina Casini, Flavio Andrea Caprioli, Maurizio Vecchi, Cristina Bezzio, Irene Bergna, Franco Radaelli, Caterina Mengoli, Sara Massironi

Summary: Disease-related malnutrition (DRM) is prevalent in inflammatory bowel disease (IBD) patients, with a rate of 23% and no significant difference between Crohn's disease and ulcerative colitis. DRM is associated with higher hospitalization rate, more frequent use of systemic steroids, lower levels of hemoglobin, albumin, prealbumin, and higher levels of C-reactive protein. Low BMI, current hospitalization, and hospitalization in the previous month are significantly associated with DRM.

INFLAMMATORY BOWEL DISEASES (2023)

Article Endocrinology & Metabolism

Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature?

M. Caputo, T. Daffara, A. Ferrero, M. Romanisio, E. Monti, C. Mele, M. Zavattaro, S. Tricca, A. Siani, A. Clemente, C. Palumbo, S. De Cilla, A. Carriero, A. Volpe, P. Marzullo, G. Aimaretti, F. Prodam

Summary: The aim of this study was to identify risk factors for morphological changes in adrenal incidentalomas (AIs) during follow-up. High body weight, dehydroepiandrosterone sulfate (DHEAS), and direct renin concentration (DRC) were found to be associated with tumor enlargement, while aldosterone levels were lower in these cases. Additionally, glaucoma and dysglycemia had a higher prevalence in patients with tumor enlargement and were identified as independent predictors.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Endocrinology & Metabolism

Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study

Martina Romanisio, Rosa Pitino, Alice Ferrero, Francesca Pizzolitto, Samuele Costelli, Valentina Antoniotti, Paolo Marzullo, Gianluca Aimaretti, Flavia Prodam, Marina Caputo

Summary: This study evaluated metabolic comorbidities in surgically treated acromegalic patients and found that the discrepancy between GH and IGF-1 levels does not appear to be a risk factor for their presence or persistence. Further extended studies are needed to confirm these results in the long term.

FRONTIERS IN ENDOCRINOLOGY (2023)

Review Endocrinology & Metabolism

A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature

Valentina Mancioppi, Tommaso Daffara, Martina Romanisio, Giovanni Ceccarini, Caterina Pelosini, Ferruccio Santini, Simonetta Bellone, Simona Mellone, Alessio Baricich, Ivana Rabbone, Gianluca Aimaretti, Baris Akinci, Mara Giordano, Flavia Prodam

Summary: This article describes a rare lipodystrophy syndrome called congenital generalized lipodystrophy type 4 (CGL4), which is caused by mutations in the PTRF gene. Two early childhood patients presented with features such as reduced subcutaneous fat, muscular hypertrophy, distinctive facial features, myopathy, and atlantoaxial instability. Blood tests showed elevated CK and triglyceride levels, and undetectable leptin and adiponectin concentrations.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Oncology

Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study

Edda Cava, Daniele Spadaccini, Gianluca Aimaretti, Paolo Marzullo, Beatrice Cavigiolo, Deborah Farinelli, Alessandra Gennari, Chiara Saggia, Maria Grazia Carbonelli, Sergio Riso, Flavia Prodam

Summary: This retrospective observational cohort study aimed to assess the impact of a Mediterranean diet on weight and anthropometric changes in women completing active breast cancer treatment. The study found that implementing a Mediterranean diet can lead to weight and anthropometric improvements in breast cancer survivors. However, further research is necessary to explore the long-term effects of weight loss on these individuals and consider specific predictors of dropout.

CANCERS (2023)

Meeting Abstract Gastroenterology & Hepatology

Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature

L. F. Pisani, G. Crespi, M. Mellai, C. Flavio, M. L. Annunziata, M. Manfredi, P. Luca, C. Porta

JOURNAL OF CROHNS & COLITIS (2023)

Article Medicine, General & Internal

Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis receiving haemodialysis in end-stage kidney failure: A case report

Guglielmo Albertini Petroni, Laura Francesca Pisani, Edoardo Borsotti, Maria Doria, Maria Laura Annunziata

Summary: This report describes the clinical efficacy and safety of vedolizumab in a patient with severe ulcerative colitis on haemodialysis. The patient had a severe flare-up of the disease and developed steroid dependence. Vedolizumab was used as maintenance therapy and was well tolerated without any adverse events.

SAGE OPEN MEDICAL CASE REPORTS (2023)

No Data Available